Zdrowie i gospodarka · 17/08/2020

FDA Proposes Reclassification of Non-Invasive Bone Growth Stimulators

The FDA is proposing to reclassify non-invasive bone growth stimulators, currently classified as Class III devices, into Class II, subject to premarket notification, in an effort to reduce regulatory burdens and streamline the approval process.